《Npj Breast Cancer》重点专注发布Medicine-Pharmacology (medical)领域的新研究，旨在促进和传播该领域相关的新技术和新知识。鼓励该领域研究者详细地发表他们的高质量实验研究和理论结果。根据网友分享的投稿经验，平均审稿速度为 9 Weeks 。该杂志创刊至今，在Medicine-Pharmacology (medical)领域，影响力非凡，对来稿文章质量要求很高，稿件投稿过审难度很大，刊登文章的学术水平和编辑质量在同类杂志中均名列前茅。如果你想在该杂志上发表论文，你可以向编辑部提交文章，但文章必须具有重要意义并代表该领域专业的发展。我们欢迎广大同领域的研究者提交投稿。
| CiteScore | SJR | SNIP | CiteScore排名 | |||
|---|---|---|---|---|---|---|
| 10.1 | 2.275 | 1.341 | 学科类别 | 分区 | 排名 | 百分位 |
|
大类：大类：Medicine
小类：小类：Pharmacology(medical)
|
Q1 | 19/272 | 93% | |||
|
大类：大类：Medicine
小类：小类：Radiology,NuclearMedicineandImaging
|
Q1 | 28/333 | 91% | |||
|
大类：大类：Medicine
小类：小类：Oncology
|
Q1 | 58/404 | 85% | |||
| 按JIF指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
|---|---|---|---|---|
| 学科：ONCOLOGY | SCIE | Q1 | 44 / 322 | 86.5% |
| 按JCI指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
|---|---|---|---|---|
| 学科：ONCOLOGY | SCIE | Q1 | 49 / 322 | 84.94% |
文章名称
引用次数
MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer
59
Image analysis with deep learning to predict breast cancer grade, ER status, histologic subtype, and intrinsic subtype
24
If we build it they will come: targeting the immune response to breast cancer
17
Exploration of PET and MRI radiomic features for decoding breast cancer phenotypes and prognosis
16
21-Gene assay as predictor of chemotherapy benefit in HER2-negative breast cancer
15
Are all cyclin-dependent kinases 4/6 inhibitors created equal?
15
Phase II study of ruxolitinib, a selective JAK1/2 inhibitor, in patients with metastatic triple-negative breast cancer
15
Simultaneous defeat of MCF7 and MDA-MB-231 resistances by a hypericin PDT-tamoxifen hybrid therapy
13
Cyclin E1 and Rb modulation as common events at time of resistance to palbociclib in hormone receptor-positive breast cancer
12
E2112: randomized phase iii trial of endocrine therapy plus entinostat/placebo in patients with hormone receptor-positive advanced breast cancer
12
国家/地区
发文量
TUSA
119
TEngland
21
TItaly
19
TCanada
16
TAustralia
14
TCHINA MAINLAND
12
TBelgium
11
TGERMANY (FED REP GER)
11
TNetherlands
10
TFrance
9
